Development of SEDDS formulation containing caffeine for dermal delivery
International Journal of Cosmetic Science · 2023-04 · 45 (2) · 255-265
DOI: 10.1111/ics.12841 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cosmetic Science, online erschienen am 14.03.2023. Verfasst von Igor de Andrade Assunção de Almeida und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Instrumental Analysis, Duque de Caxias Campus, Federal Institute of Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Caffeine, Cellulite. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.
Abstract (Originalsprache)
Objective
The objective of this work was to develop a self‐emulsifying drug delivery system (SEDDS) containing caffeine for the treatment of cellulite.
Methods
SEDDS were prepared using the solution method. 0.5% (w/v) caffeine was added to the previously selected excipients. The system was characterized by droplet size, zeta potential, emulsification time and long‐term stability. In vitro release and skin permeation were investigated using Franz‐type diffusion cells. The cytotoxicity was evaluated on normal human keratinocytes.
Results
Caffeine SEDDS were thermodynamically stable, with a zeta potential less than ‐ 22 mV and droplet size around 30 nm, and were long‐term stable. The permeation study showed that the formulation promoted caffeine accumulation in the skin layers, suggesting an increase in local circulation. Cytotoxicity studies on HaCaT cells were not conclusive as the surfactant used indicated false‐positive results due to its high molar mass.
Conclusion
It was possible to obtain a stable SEDDS that could cause an increase in blood flow in the applied area, resulting in cellulite reduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Instrumental Analysis, Duque de Caxias Campus, Federal Institute of Rio de Janeiro, Rio de Janeiro, Brazil.
- Department of Pharmaceutics and Medicines, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
ORCID-Profile: Lucio Mendes Cabral, Letícia Coli Louvisse de Abreu
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Zitieren
APA
de Almeida, I. A. A., Honório, T. D. S., do Carmo, F. A., de Freitas, Z. M. F., Simon, A., Rangel Rodrigues, C., Pereira de Sousa, V., Cabral, L. M., & de Abreu, L. C. L. (2023). Development of SEDDS formulation containing caffeine for dermal delivery. International Journal of Cosmetic Science, 45(2), 255-265. https://doi.org/10.1111/ics.12841
Vancouver
de Almeida IAA, Honório TDS, do Carmo FA, de Freitas ZMF, Simon A, Rangel Rodrigues C, et al. Development of SEDDS formulation containing caffeine for dermal delivery. International Journal of Cosmetic Science. 2023;45(2):255-265. doi:10.1111/ics.12841
BibTeX
@article{deAlmeida2023,
author = {de Almeida, Igor de Andrade Assunção and Honório, Thiago da Silva and do Carmo, Flavia Almada and de Freitas, Zaida Maria Faria and Simon, Alice and Rangel Rodrigues, Carlos and Pereira de Sousa, Valeria and Cabral, Lucio Mendes and de Abreu, Letícia Coli Louvisse},
title = {Development of SEDDS formulation containing caffeine for dermal delivery},
journal = {International Journal of Cosmetic Science},
year = {2023},
volume = {45},
number = {2},
pages = {255--265},
doi = {10.1111/ics.12841}
}
EUVIMED